Cellgentek

Cellgentek is a South Korean biotechnology company specializing in the development of next-generation cell and gene therapies through its proprietary Cell-based Medicine (CBM) platform. The company focuses on creating 'living factories' by engineering cells to continuously produce and secrete therapeutic proteins directly within the patient's body, aiming to overcome the limitations of traditional protein injections. Their pipeline targets a broad range of chronic and degenerative conditions, including metabolic diseases like diabetes and obesity, autoimmune disorders, and neurodegenerative diseases. By leveraging advanced gene delivery and cell encapsulation technologies, Cellgentek seeks to provide long-term, stable therapeutic effects with improved patient compliance.